Stockscreener 앱 받기
14.50
0.41%
-0.06
Neuropace Inc 주식(NPCE)의 최신 뉴스
Essex Investment Management Co. LLC Raises Holdings in NeuroPace, Inc. $NPCE - MarketBeat
How Does NeuroPace's Personalized Technology Transform Seizure Control - Kalkine Media
NeuroPace, Inc. (NASDAQ:NPCE) Receives Average Recommendation of "Moderate Buy" from Brokerages - MarketBeat
Aug Intraday: Is NeuroPace Inc a stock for growth or value investorsBond Market & High Conviction Buy Zone Alerts - baoquankhu1.vn
Neuropace, Inc. (NPCE) Stock Analysis: Exploring the 25.89% Potential Upside and Analyst Optimism - DirectorsTalk Interviews
Trading Systems Reacting to (NPCE) Volatility - Stock Traders Daily
How NeuroPace (NPCE) Analysts Are Quietly Rewriting The Story Behind The Stock - Yahoo Finance
NeuroPace stock price target raised to $20 from $19 at Leerink Partners By Investing.com - Investing.com Australia
NeuroPace stock price target raised to $20 from $19 at Leerink Partners - Investing.com Nigeria
Neuropace, Inc. (NPCE) Investor Outlook: A Medical Device Innovator with 26% Potential Upside - DirectorsTalk Interviews
FY2025 EPS Estimates for NeuroPace Lifted by HC Wainwright - MarketBeat
NeuroPace stock price target raised to $19 from $18 at H.C. Wainwright - Investing.com Nigeria
NeuroPace stock price target raised to $19 from $18 at H.C. Wainwright By Investing.com - Investing.com Canada
Beyond The Numbers: 5 Analysts Discuss NeuroPace Stock - Benzinga
NeuroPace price target raised to $19 from $18 at H.C. Wainwright - TipRanks
Juniper Biomedical Appoints Frank Fischer To Board - citybiz
CORRECTING and REPLACING Juniper Biomedical Wins Neuromod Prize and Welcomes Frank Fischer to Board of Directors - The AI Journal
NeuroPace, Inc. (NASDAQ:NPCE) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
NeuroPace, Inc. (NASDAQ:NPCE) Given Average Recommendation of “Moderate Buy” by Brokerages - Defense World
NeuroPace sees Q4 revenue of about $26.6M - MSN
NeuroPace stock rises as UBS reiterates Buy rating after strong Q4 revenue - Investing.com Australia
NeuroPace stock rises as UBS reiterates Buy rating after strong Q4 revenue By Investing.com - Investing.com South Africa
US-based NeuroPace revenue expected to grow 24% in Q4 2025 - Medical Buyer
Profit Recap: Will NeuroPace Inc stock benefit from M AWeekly Profit Summary & Growth Focused Stock Pick Reports - baoquankhu1.vn
NeuroPace reports 25% revenue growth for 2025, projects steady growth By Investing.com - Investing.com Nigeria
NeuroPace Reports Preliminary Q4, 2025 Revenue; Sets 2026 Guidance - marketscreener.com
NeuroPace (NASDAQ:NPCE) Shares Gap UpShould You Buy? - MarketBeat
NeuroPace Reports Preliminary Unaudited Results for the Fourth Quarter and Fiscal Year 2025 and Initial 2026 Outlook - Investing News Network
NeuroPace, Inc. Provides Earnings Guidance for the First Quarter and Full Year of Fiscal 2026 - marketscreener.com
NeuroPace reports 25% revenue growth for 2025, projects steady growth - Investing.com
NeuroPace (NASDAQ:NPCE) and Envoy Medical (NASDAQ:COCH) Critical Comparison - Defense World
NeuroPace (NASDAQ:NPCE) Stock Price Down 4.4% – What’s Next? - Defense World
Neurological Implants Market to Reach USD 12.39 Billion by 2031 | - openPR.com
Neuropace, Inc. (NPCE) Investor Outlook: Exploring the 13.5% Potential Upside in Medical Devices - DirectorsTalk Interviews
NeuroPace (NASDAQ:NPCE) Shares Down 4.4%Should You Sell? - MarketBeat
How resilient is NeuroPace Inc. stock in market downturnsDay Trade & Safe Investment Capital Preservation Plans - ulpravda.ru
When Will NeuroPace, Inc. (NASDAQ:NPCE) Turn A Profit? - 富途资讯
NeuroPace (NASDAQ:NPCE) Has Debt But No Earnings; Should You Worry? - simplywall.st
Financial Review: Vicarious Surgical (NYSE:RBOT) vs. NeuroPace (NASDAQ:NPCE) - Defense World
How NeuroPace Inc. stock performs in rate cut cyclesJuly 2025 Breakouts & Risk Managed Investment Strategies - Улправда
Is NeuroPace Inc. stock oversold or undervaluedMarket Activity Recap & Stepwise Entry/Exit Trade Alerts - ulpravda.ru
Will NeuroPace Inc. stock benefit from green energy trendsWatch List & High Conviction Investment Ideas - ulpravda.ru
Why NeuroPace Inc. stock remains undervaluedGlobal Market Influence & Low Risk Capital Appreciation - Улправда
NeuroPace (NASDAQ:NPCE) Sees Strong Trading VolumeHere's Why - MarketBeat
NeuroPace stock dips after pricing $65M share offering - MSN
Can NeuroPace Inc. stock deliver sustainable ROE2026 world cup usa national team third place match playmakers high defensive line expert forecast breakdown - ulpravda.ru
UBS sees upside for NeuroPace shares with 22% CAGR and market expansion drivers - MSN
User | bigspringherald.comNeuropace, Inc.Common Stock (Nasdaq:NPCE) Stock Quote - FinancialContent
UBS Initiates Coverage of NeuroPace (NPCE) with Buy Recommendation - MSN
Responsive Playbooks and the NPCE Inflection - Stock Traders Daily
0.45%
0.31%
자본화:
|
볼륨(24시간):